ZA977327B - Pharmaceutical composition containing 4-oxobutanoic acids. - Google Patents

Pharmaceutical composition containing 4-oxobutanoic acids.

Info

Publication number
ZA977327B
ZA977327B ZA9707327A ZA977327A ZA977327B ZA 977327 B ZA977327 B ZA 977327B ZA 9707327 A ZA9707327 A ZA 9707327A ZA 977327 A ZA977327 A ZA 977327A ZA 977327 B ZA977327 B ZA 977327B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
composition containing
oxobutanoic acids
oxobutanoic
acids
Prior art date
Application number
ZA9707327A
Other languages
English (en)
Inventor
Gerard Moinet
Micheline Kergoat
Didier Mesangeau
Liliane Doare
Philippe Maizeray
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA977327B publication Critical patent/ZA977327B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
ZA9707327A 1996-08-16 1997-08-14 Pharmaceutical composition containing 4-oxobutanoic acids. ZA977327B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9610254A FR2752422B1 (fr) 1996-08-16 1996-08-16 Composition pharmaceutique contenant des acides 4-oxo-butanoiques

Publications (1)

Publication Number Publication Date
ZA977327B true ZA977327B (en) 1998-03-30

Family

ID=9495089

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9707327A ZA977327B (en) 1996-08-16 1997-08-14 Pharmaceutical composition containing 4-oxobutanoic acids.

Country Status (30)

Country Link
US (1) US6143787A (id)
EP (1) EP0925273B1 (id)
JP (1) JP3105545B2 (id)
KR (1) KR100488430B1 (id)
CN (1) CN1082370C (id)
AR (1) AR009251A1 (id)
AT (1) ATE208364T1 (id)
AU (1) AU725440B2 (id)
BR (1) BR9711315A (id)
CA (1) CA2263348C (id)
CY (1) CY2298B1 (id)
CZ (1) CZ294165B6 (id)
DE (1) DE69708130T2 (id)
DK (1) DK0925273T3 (id)
ES (1) ES2166098T3 (id)
FR (1) FR2752422B1 (id)
HK (1) HK1021728A1 (id)
HU (1) HUP0004223A3 (id)
ID (1) ID17875A (id)
NO (1) NO312290B1 (id)
PL (1) PL187371B1 (id)
PT (1) PT925273E (id)
RU (1) RU2175966C2 (id)
SI (1) SI0925273T1 (id)
SK (1) SK283055B6 (id)
TR (1) TR199900329T2 (id)
TW (1) TW438764B (id)
UA (1) UA57031C2 (id)
WO (1) WO1998007681A1 (id)
ZA (1) ZA977327B (id)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04318852A (ja) * 1991-04-18 1992-11-10 Fujitsu Ltd レジスト・パターン形成方法
CN100344616C (zh) 2001-06-12 2007-10-24 维尔斯达医疗公司 用于治疗代谢失调的化合物
FR2832633B1 (fr) * 2001-11-28 2004-09-24 Lipha Composition pharmaceutique comprenant une association metformine et un acide 4-oxo-butanoique et son utilisation pour traiter le diabete
FR2832925B1 (fr) * 2001-12-03 2006-07-14 Lipha Utilisation de derives de l'acide 4-oxobutanoique dans le traitement de l'inflammation
FR2834214B1 (fr) * 2001-12-28 2004-09-24 Lipha Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un acide 4-oxo-butanoique et son utilisation pour traiter le diabete
FR2834640B1 (fr) * 2002-01-11 2004-09-24 Lipha Composition pharmaceutique comprenant une glitazone et un acide 4-oxobutanoique et son utilisation pour traiter le diabete
EP1556085A4 (en) * 2002-11-01 2012-08-22 Wellstat Therapeutics Corp COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
EP1575575B1 (en) * 2002-11-08 2010-05-19 High Point Pharmaceuticals, LLC Safe chemical uncouplers for the treatment of obesity
FR2849599B1 (fr) * 2003-01-07 2006-12-29 Merck Sante Sas Utilisation d'inhibiteurs de la kynurenine-3-hydroxylase pour le traitement du diabete
FR2849598B1 (fr) * 2003-01-07 2006-09-22 Merck Sante Sas Utilisation d'inhibiteurs de la kynurenine-3-hydroxylase pour le traitement du diabete, par augmentation du nombre de cellules des ilots de langerhans
CN101912380A (zh) * 2003-04-15 2010-12-15 维尔斯达医疗公司 用于治疗代谢紊乱的化合物
WO2009071161A1 (en) 2007-12-03 2009-06-11 Merck Patent Gmbh Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK523288A (da) * 1987-10-06 1989-04-07 Hoffmann La Roche Aminosyrederivater
US5250517A (en) * 1987-10-06 1993-10-05 Hoffmann-La Roche Inc. Renin inhibiting compounds
CA1329680C (en) * 1987-11-23 1994-05-17 Harold Norris Weller, Iii N-heterocyclic alcohol derivatives
US5055466A (en) * 1987-11-23 1991-10-08 E. R. Squibb & Sons, Inc. N-morpholino derivatives and their use as anti-hypertensive agents

Also Published As

Publication number Publication date
KR20000068106A (ko) 2000-11-25
HK1021728A1 (en) 2000-06-30
FR2752422A1 (fr) 1998-02-20
ATE208364T1 (de) 2001-11-15
PT925273E (pt) 2002-04-29
CN1227538A (zh) 1999-09-01
EP0925273A1 (fr) 1999-06-30
BR9711315A (pt) 1999-08-17
US6143787A (en) 2000-11-07
RU2175966C2 (ru) 2001-11-20
ES2166098T3 (es) 2002-04-01
ID17875A (id) 1998-02-05
HUP0004223A2 (hu) 2001-04-28
CN1082370C (zh) 2002-04-10
SI0925273T1 (en) 2002-04-30
DE69708130T2 (de) 2002-06-20
KR100488430B1 (ko) 2005-05-10
CZ49899A3 (cs) 1999-05-12
SK283055B6 (sk) 2003-02-04
EP0925273B1 (fr) 2001-11-07
SK18099A3 (en) 2000-03-13
FR2752422B1 (fr) 1998-11-06
CA2263348C (en) 2008-05-13
NO312290B1 (no) 2002-04-22
JP2000506543A (ja) 2000-05-30
NO990707D0 (no) 1999-02-15
UA57031C2 (uk) 2003-06-16
PL331645A1 (en) 1999-08-02
PL187371B1 (pl) 2004-06-30
WO1998007681A1 (fr) 1998-02-26
CZ294165B6 (cs) 2004-10-13
TW438764B (en) 2001-06-07
AU3942297A (en) 1998-03-06
TR199900329T2 (xx) 1999-04-21
DE69708130D1 (de) 2001-12-13
AU725440B2 (en) 2000-10-12
AR009251A1 (es) 2000-04-12
DK0925273T3 (da) 2002-02-18
JP3105545B2 (ja) 2000-11-06
HUP0004223A3 (en) 2001-12-28
NO990707L (no) 1999-02-15
CY2298B1 (en) 2003-07-04
CA2263348A1 (fr) 1998-02-26

Similar Documents

Publication Publication Date Title
ZA965190B (en) Pharmaceutical composition.
ZA9710071B (en) Pharmaceutical composition.
ZA9711508B (en) Rapidly disintegrable pharmaceutical composition.
ZA9710927B (en) Pharmaceutical composition.
ZA975533B (en) Cyclosporin-containing pharmaceutical composition.
ZA974735B (en) Pharmaceutical compositions.
HK1027957A1 (en) Pharmaceutical composition.
ZA977104B (en) Pharmaceutical compositions.
ZA9710272B (en) Pharmaceutical compositions comprising diaryl-cyclomethylenpyrazole compounds.
ZA989680B (en) Pharmaceutical composition.
ZA968081B (en) Pharmaceutical composition.
GB9610359D0 (en) Pharmaceutical compositions
ZA977327B (en) Pharmaceutical composition containing 4-oxobutanoic acids.
ZA987392B (en) Pharmaceutical composition.
ZA979726B (en) Pharmaceutical compositions
ZA972602B (en) Pharmaceutical compositions.
GB9613457D0 (en) Pharmaceutical compositions
GB9623962D0 (en) Pharmaceutical composition
GB9618376D0 (en) Pharmaceutical compositions
GB9610136D0 (en) Pharmaceutical compositions
HUP0003528A3 (en) Pharmaceutical compositions containing dihydropolyprenols
ZA979447B (en) Pharmaceutical composition.
ZA966486B (en) Pharmaceutical Composition.
ZA976028B (en) Pharmaceutical compositions.
ZA976795B (en) Pharmaceutical formulation.